These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7308265)

  • 21. Potentiation of antitumor effect of cyclophosphamide and hydrazine sulfate by treatment with the antidiabetic agent, 1-phenylethylbiguanide (phenformin).
    Dilman VM; Anisimov VN
    Cancer Lett; 1979 Oct; 7(6):357-61. PubMed ID: 509414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternation of chemotherapy and radiotherapy in cancer management. III. Results in experimental solid tumor systems and their relationship to clinical studies.
    Looney WB; Hopkins HA
    Cancer Treat Rep; 1986 Jan; 70(1):141-62. PubMed ID: 3002620
    [No Abstract]   [Full Text] [Related]  

  • 23. Radiosensitizing effect of hyperthermia on mouse squamous cell carcinoma.
    Yoshino T
    Fukuoka Igaku Zasshi; 1981 Oct; 72(10):521-31. PubMed ID: 7327497
    [No Abstract]   [Full Text] [Related]  

  • 24. Adriamycin/cyclophosphamide combination chemotherapy: the importance of drug scheduling.
    Mulder JH; van Putten LM
    Eur J Cancer (1965); 1979 Dec; 15(12):1503-9. PubMed ID: 294960
    [No Abstract]   [Full Text] [Related]  

  • 25. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN; Miloushev AS
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitization of combined cis-platinum and cyclophosphamide by local hyperthermia in mice bearing the Lewis lung carcinoma.
    Hazan G; Lurie H; Yerushalmi A
    Oncology; 1984; 41(1):68-9. PubMed ID: 6538329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemo-immunotherapy of murine tumors using interleukin-2 (IL-2) and cyclophosphamide. IL-2 can facilitate or inhibit tumor growth depending on the sequence of treatment and the tumor type.
    Kedar E; Ben-Aziz R; Epstein E; Leshem B
    Cancer Immunol Immunother; 1989; 29(1):74-8. PubMed ID: 2785003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of sequence of combined radiation and cyclophosphamide regimens on murine osteosarcoma.
    El-Mahdi AM; Shaeffer J
    Cancer Treat Rep; 1977 Nov; 61(8):1569-71. PubMed ID: 270390
    [No Abstract]   [Full Text] [Related]  

  • 29. Preliminary results in the treatment of oat cell carcinoma of the lung by combined application of chemotherapy (CT) and whole-body hyperthermia.
    Engelhardt R; Neumann H; von der Tann M; Löhr GW
    Prog Clin Biol Res; 1982; 107():761-5. PubMed ID: 6300932
    [No Abstract]   [Full Text] [Related]  

  • 30. Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide.
    Twentyman PR
    Br J Cancer; 1977 Feb; 35(2):208-17. PubMed ID: 836758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of surgery, chemotherapy and immunotherapy on Lewis lung tumour.
    Thompson RB; Alberola V; Mathé G
    Rev Eur Etud Clin Biol; 1972 Nov; 17(9):900-2. PubMed ID: 4653992
    [No Abstract]   [Full Text] [Related]  

  • 32. An experimental tumour model for the study of the effects of chemotherapy and immunotherapy in combination with surgery.
    Winsey HS; Mathé G; Thompson R
    Br J Surg; 1971 Apr; 58(4):303. PubMed ID: 5572349
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclophosphamide chemotherapy of intrapulmonarily implanted Lewis lung carcinoma.
    Ho W; Furst A
    Proc West Pharmacol Soc; 1978; 21():397-400. PubMed ID: 693524
    [No Abstract]   [Full Text] [Related]  

  • 34. Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukaemia and Lewis tumour.
    Mathé G; Halle-Pannenko O; Bourut C
    Eur J Cancer (1965); 1977 Oct; 13(10):1095-8. PubMed ID: 923609
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of hyperthermia on survival in transplanted lymphosarcoma.
    Malangoni MA; Grosfeld JL; Cakmak O; Ballantine TV
    J Pediatr Surg; 1978 Dec; 13(6D):740-5. PubMed ID: 581592
    [No Abstract]   [Full Text] [Related]  

  • 36. Does whole-body hyperthermia therapy involve participation of the immune system?
    Roszkowski W; Wrembel JK; Roszkowski K; Janiak M; Szmigielski S
    Int J Cancer; 1980 Feb; 25(2):289-92. PubMed ID: 7390652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of resistance to tumor growth of athymic nude mice pretreated by combined local hyperthermia and X-irradiation.
    Yerushalmi A; Weinstein Y
    Cancer Res; 1979 Mar; 39(3):1126-8. PubMed ID: 311680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival of mice with metastatic osteosarcoma treated by cyclophosphamide or radiotherapy.
    Shaeffer J; El-Mahdi AM; Constable WC
    Cancer Res; 1975 Dec; 35(12):3596-8. PubMed ID: 1059504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced effect of systemic cyclophosphamide by local tumor hyperthermia in mice.
    Loven D; Lurie H; Hazan G
    Cancer Treat Rep; 1986 Apr; 70(4):509-12. PubMed ID: 3698044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of radiation or cyclophosphamide versus alternated radiation and cyclophosphamide treatment of primary tumor and pulmonary metastases.
    Looney WB; Hopkins HA
    NCI Monogr; 1988; (6):145-6. PubMed ID: 3352757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.